Table 3.
Results from Multivariable Regression Models Examining Associations between Demographic, Metabolic Risk Indicators, and Mental Health Correlates of Self-Reported Erectile Dysfunction among 18–31 Year-Old, Sexually Active Men in the US Growing Up Today Study, 2013 Data (n= 2,660)
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Demographic | ||||
| Age | 0.96 (0.90, 1.03) | 1.02 (0.94, 1.10) | ||
| Married/Living with a Partner | 0.36 (0.21, 0.63) | 0.0004 | 0.35 (0.19, 0.65) | 0.0009 |
| Metabolic Syndrome Risk Indicators | ||||
| Overweight or Obese | 0.52 (0.26, 1.04) | |||
| Waist Circumference >40 in. | 0.39 (0.12, 1.23) | |||
| Diabetes | 1.02 (0.14, 7.10) | |||
| Hypertension | 0.52 (0.16, 1.63) | |||
| Hypercholesterolemia | 1.07 (0.50, 2.31) | |||
| Approx. Metabolic Syndrome Score | 0.71 (0.48, 1.07) | |||
| Mental Health Indicators | ||||
| Depression | 2.61 (1.58, 4.32) | 0.0002 | 1.46 (0.82, 2.60) | |
| SSRIs | 3.56 (1.93, 6.56) | <0.0001 | ||
| Other Antidepressants (e.g., Elavil) | 5.02 (2.42, 10.38) | <0.0001 | ||
| Any Antidepressants | 4.42 (2.61, 7.48) | <0.0001 | 3.45 (1.87, 6.36) | <0.0001 |
| Anxiety | 2.63 (1.52, 4.54) | 0.0005 | 2.07 (1.19, 3.60) | 0.0105 |
| Tranquilizers (e.g., Valium, Xanax) | 4.19 (2.03, 8.65) | <0.0001 | 2.72 (1.31, 5.64) | 0.0073 |
Model 1: Individual bivariate associations with moderate-to-severe erectile dysfunction (IIEF-5 scores ≤16; mild and no erectile dysfunction [IIEF-5 scores >16] as the referent).
Model 2: Grouped bivariate (demographic; approximate metabolic syndrome score [count of metabolic risk indicators]; depression and any antidepressants; anxiety and tranquilizers) associations with moderate-to-severe erectile dysfunction (IIEF-5 scores ≤16; mild and no erectile dysfunction [IIEF-5 scores >16] as the referent).